IP Library › Granted Patent US 7,235,643
Granted Patent B2
US 7,235,643 · App. 10/243,130 · Granted Jun 26, 2007

Antibodies and methods for generating genetically altered antibodies with high affinity

Assignee: Morphotek, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,235,643
App. No.
10/243,130
Granted
Jun 26, 2007
Kind
B2
Abstract

Dominant negative alleles of human mismatch repair genes can be used to generate hypermutable cells and organisms. By introducing these genes into cells and transgenic animals, new cell lines and animal varieties with novel and useful properties can be prepared more efficiently than by relying on the natural rate of mutation. These methods are useful for generating genetic diversity within immunoglobulin genes directed against an antigen of interest to produce altered antibodies with enhanced biochemical activity. Moreover, these methods are useful for generating antibody-producing cells with increased level of antibody production. The invention also provides methods for increasing the affinity of monoclonal antibodies and monoclonal antibodies with increased affinity.

Claims (5)

1. A method for producing a monoclonal antibody having an increased affinity for the antigen to which it binds relative to a monoclonal antibody comprising a heavy chain variable region comprising SEQ ID NO: 18, the method comprising substituting Alanine at the sixth position of SEQ ID NO:18 with Proline, whereby the affinity of the produced monoclonal antibody for said antigen is increased.

2. The method of claim 1 , further comprising substituting Valine at the ninth position of SEQ ID NO:18 with Glycine.

3. The method of claim 1 , further comprising substituting Valine at the ninth position of SEQ ID NO:18 with Arginine.

4. The method of claim 1 , 2 or 3 , further comprising substituting Arginine at the tenth position of SEQ ID NO:18 with Lysine.

5. An antibody produced by the method of claim 1 , 2 , 3 , or 4 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2018
From: MORPHOTEK, INC.
To: EISAI, INC.
Reel/Frame 047248/0608 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2002
From: NICOLAIDES, NICHOLAS C.; GRASSO, LUIGI; SASS, PHILIP M.
To: MORPHOTEK, INC.
Reel/Frame 013577/0356 →
Continuity (2)
Continuation In Part 0970746800 · Nov 7, 2000
Related Publication 20030143682A1 · Jul 31, 2003